CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells

Mi Hyun Kang, Sung Ung Moon, Ji Hea Sung, Jin Won Kim, Keun Wook Lee, Hye Seung Lee, Jong Seok Lee, Jee Hyun Kim

Cancer Research and Treatment. 2016;48(1):355-364. Published online 2015 March 5 DOI: https://doi.org/10.4143/crt.2014.260

Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells

Mi Hyun Kang, Sung Ung Moon, Ji Hea Sung, Jin Won Kim, Keun Wook Lee, Hye Seung Lee, Jong Seok Lee, Jee Hyun Kim

Cancer Research and Treatment. 2016;48(1):355-364

Link1

Link2 Link3

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

Hyun-Jin Nam, Hwang-Phill Kim, Young-Kwang Yoon, Hyung-Seok Hur, Sang-Hyun Song, Maeng-Sup Kim, Gwan-Sun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim

Cancer Letters. 2011;302(2):155-165

Link1 Link2

Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo

Qiong He, Jing Gao, Sai Ge, Tingting Wang, Yanyan Li, Zhi Peng, Yilin Li, Lin Shen

Journal of Cancer Research and Clinical Oncology. 2014;140(9):1575-1583

Link1

Link2 Link3

562 Antitumor Activity of the Polo-like Kinase (PLK) Inhibitor, TAK-960, Alone and in Combination with Standard Agents Against KRAS WT and MT Colorectal Cancer (CRC) Models

T. Pitts, K.L. McPhillips, H.M. Selby, A. Spreafico, S.M. Bagby, B.C. Britt, J.J. Tentler, A.C. Tan, K. Kuida, S.G. Eckhardt

European Journal of Cancer. 2012;48:172-173

Link1 Link2

Antitumor Effect of PSK at a Distant Site: Tumor-specific Immunity and Combination with Other Chemotherapeutic Agents

Takusaburo Ebina, Kazuko Murata

Japanese Journal of Cancer Research. 1992;83(7):775-782

Link1

Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan

Shousong Cao, Farukh A. Durrani, Youcef M. Rustum

Clinical Colorectal Cancer. 2005;4(5):336-343

Link1 Link2

Lonidamine Alone and in Combination with Other Chemotherapeutic Agents in the Treatment of Cancer Patients

G. Pacilio, G. Carteni, M. Biglietto, M. De Cesare

Oncology. 1984;41(1):108-112

Link1 Link2

Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry

Eunyoung Kim, Hankyong Kim, Kweehyun Suh, Sechang Kwon, Gwansun Lee, Na Hyun Park, Jongki Hong

Rapid Communications in Mass Spectrometry. 2013;27(11):1183-1195

Link1 Link2 Link3

Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models

Mi Young Cha, Kwang-Ok Lee, Mira Kim, Ji Yeon Song, Kyu Hang Lee, Jongmin Park, Yun Jung Chae, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee, Seung Bum Park, Maeng Sup Kim

International Journal of Cancer. 2011;130(10):2445-2454

Link1

6632 Characterisation of the response of pancreatic cancer cells to treatment with chemotherapeutic agents alone and in combination with tyrosine kinase inhibitors

R. Sheikh, R. O'connor, N. Walsh, M. Clynes, R. Mcdermott

European Journal of Cancer Supplements. 2009;7(2):399

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.